Clinical Trials
11
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials
A Clinical Trial to Evaluate Efficacy and Safety of Two Different Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis
- Conditions
- Mild to Moderate Plaque Psoriasis
- Interventions
- Drug: Calcipotriol/AKVANO, 50 μg/g cutaneous solutionOther: Placebo
- First Posted Date
- 2022-01-03
- Last Posted Date
- 2022-03-03
- Lead Sponsor
- Cadila Pharnmaceuticals
- Target Recruit Count
- 278
- Registration Number
- NCT05174598
- Locations
- 🇮🇳
AC Subbareddy Government Hospital, Nellore, Andhra Pradesh, India
🇮🇳Downtown Hospital, Guwahati, Assam, India
🇮🇳Marwari Hospital & Research Centre, Guwahati, Assam, India
Effect of CPL-2009-0031 in the Treatment of Patients With Uncontrolled Type 2 Diabetes Mellitus
- Conditions
- Uncontrolled Type 2 Diabetes Mellitus
- Interventions
- Drug: CPL-2009-0031 140 mg
- First Posted Date
- 2021-03-16
- Last Posted Date
- 2021-08-17
- Lead Sponsor
- Cadila Pharnmaceuticals
- Target Recruit Count
- 355
- Registration Number
- NCT04801199
- Locations
- 🇮🇳
A C Subba Reddy Government Medical College and Hospital, Nellore, Andhra Pradesh, India
🇮🇳Downtown Hospital, Guwahati, Assam, India
🇮🇳SSG Hospital, Vadodara, Gujarat, India
Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill
- Conditions
- COVID-19
- Interventions
- First Posted Date
- 2020-04-24
- Last Posted Date
- 2020-12-22
- Lead Sponsor
- Cadila Pharnmaceuticals
- Target Recruit Count
- 480
- Registration Number
- NCT04358809
- Locations
- 🇮🇳
All India Institute of Medical Science, Raipur, Raipur, Chhattisgarh, India
🇮🇳All India Institute of Medical Sciences, Bhopal, Bhopal, India
🇮🇳Post Graduate Institute of Medical Education and Research, Chandigarh, India
Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19
- Conditions
- COVID-19
- Interventions
- First Posted Date
- 2020-04-20
- Last Posted Date
- 2020-12-22
- Lead Sponsor
- Cadila Pharnmaceuticals
- Target Recruit Count
- 4000
- Registration Number
- NCT04353518
- Locations
- 🇮🇳
All India Institute of Medical Sciences, Bhopal, Bhopal, Madhya Pradesh, India
🇮🇳Post Graduate Institute of Medical Education and Research, Chandigarh, India
🇮🇳All lndia Institute of Medical Science, Delhi, Delhi, India
A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients
- Conditions
- COVID-19
- Interventions
- First Posted Date
- 2020-04-15
- Last Posted Date
- 2021-01-27
- Lead Sponsor
- Cadila Pharnmaceuticals
- Target Recruit Count
- 40
- Registration Number
- NCT04347174
- Locations
- 🇮🇳
All India Institute of Medical Science, Raipur, Raipur, Chhattisgarh, India
🇮🇳All India Institute of Medical Sciences, Bhopal, Bhopal, Madhya Pradesh, India
🇮🇳Postgraduate Institute of Medical Education and Research, Chandigarh, India
- Prev
- 1
- 2
- 3
- Next